高剂量静脉注射拉科萨米德推送的安全性概况
Sterling C Torian1, G Morgan Jones2,3
1Department of Pharmacy, Tristar Centennial Medical Center, Nashville, TN, USA.
The Neurohospitalist
|July 13, 2023
概括
高剂量静脉注射的300毫克和400毫克的拉科萨米德 (LCM) 是安全的治疗状态 (SE). 这种快速注射方法显示,患者的输液反应,低血压或心的风险没有增加.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
背景情况:
- 状态 (SE) 需要迅速有效的治疗.
- 拉科萨米德 (LCM) 的静脉输入 (IVP) 给药提供了快速的分娩.
- 关于高剂量IVP LCM (300 mg和400 mg) 的安全性数据有限.
研究的目的:
- 评估高剂量IVPLCM (300 mg和400 mg) 的安全性.
- 为了评估输液部位反应的发生率,低血压,和在给药后2小时内心肌梗塞.
- 为了确定PR延长率作为次要结果.
主要方法:
- 单中心,回顾性,单臂分析.
- 包括接受IVPLCM300毫克或400毫克的患者.
- 评估主要结局 (输液部位反应,低血压,心肌梗塞) 和次要结局 (PR延长).
主要成果:
- 评估了113名患者,85.8%接受了400毫克IVPLCM.
- 输液反应的发生率:6.2% (7/113).
- 低血压的发生率:11.1% (12/108);没有报告的胸肌梗塞. 不良事件不太可能与LCM相关.
结论:
- 高剂量的IVPLCM (300 mg和400 mg) 是快速治疗SE的安全选择.
- 这种注射途径不会增加输液部位反应,低血压或心拍的风险.
- 进一步的研究可能会支持在高急性环境中更广泛地采用.
更多相关视频
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
213
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.5K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Local Anesthetics: Adverse Effects
455
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
455
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
102
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
102


